These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Author: Levant B.
    Journal: Brain Res; 1995 Nov 06; 698(1-2):146-54. PubMed ID: 8581473.
    Abstract:
    The effects of alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on the binding of [3H]7-OH-DPAT, a ligand for the D3 dopamine receptor, were assessed in ventral striatal (n. accumbens and olf. tubercle) membranes of adult, male Sprague-Dawley rats. [3H]Spiperone binding to D2-like receptors in striatal membranes was also assayed as a positive control. In vitro, EEDQ was equipotent in inactivating [3H]7-OH-DPAT- and [3H]spiperone-labeled binding sites. In vitro, [3H]spiperone binding was rapidly eliminated in a dose-dependent manner following EEDQ administration. In contrast, [3H]7-OH-DPAT binding was not significantly altered by any dose of the alkylating agent at any time point examined. Depletion of endogenous catecholamines with alpha-methyltyrosine and reserpine revealed a second, higher affinity binding site for [3H]7-OH-DPAT. Administration of EEDQ in catecholamine-depleted animals reduced [3H]7-OH-DPAT labels two distinct populations of binding binding sites in rat brain membranes, only one of which is susceptible to inactivation by EEDQ. These sites may represent high and low affinity states of the D3 receptor. In addition, this discovery may provide a useful method for examining the function of some D3 receptors in brain independent of other monoaminergic systems.
    [Abstract] [Full Text] [Related] [New Search]